Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

OPRL1 Antikörper (AA 323-370) (Biotin)

Der Kaninchen Polyklonal Anti-OPRL1-Antikörper wurde für ELISA validiert. Er ist geeignet, OPRL1 in Proben von Human zu detektieren.
Produktnummer ABIN7161666

Kurzübersicht für OPRL1 Antikörper (AA 323-370) (Biotin) (ABIN7161666)

Target

Alle OPRL1 Antikörper anzeigen
OPRL1 (Opiate Receptor-Like 1 (OPRL1))

Reaktivität

  • 40
  • 30
  • 26
  • 5
  • 5
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 38
  • 3
  • 1
Kaninchen

Klonalität

  • 40
  • 2
Polyklonal

Konjugat

  • 14
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser OPRL1 Antikörper ist konjugiert mit Biotin

Applikation

  • 30
  • 14
  • 13
  • 13
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
ELISA
  • Bindungsspezifität

    • 15
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 323-370

    Kreuzreaktivität

    Human

    Aufreinigung

    >95%, Protein G purified

    Immunogen

    Recombinant Human Nociceptin receptor protein (323-370AA)

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    OPRL1 (Opiate Receptor-Like 1 (OPRL1))

    Andere Bezeichnung

    OPRL1

    Hintergrund

    Background: G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.

    Aliases: H.sapiens mRNA for ORL1 receptor antibody, Kappa type 3 opioid receptor antibody, Kappa-type 3 opioid receptor antibody, kappa3-related opioid receptor antibody, KOR 3 antibody, KOR-3 antibody, KOR3 antibody, LC132 receptor like antibody, LC132 receptor, rat, homolog of antibody, MGC34578 antibody, Nociceptin receptor antibody, Nociceptin/orphanin FQ (N/OFQ) peptide receptor antibody, NOCIR antibody, NOP antibody, OOR antibody, Opiate receptor like 1 antibody, Opiod receptor like 1 antibody, Oprl1 antibody, OPRX_HUMAN antibody, ORL1 antibody, Orphanin FQ receptor antibody

    UniProt

    P41146
Sie sind hier:
Chat with us!